Ronco P, Beck L, Debiec H, Fervenza FC, Hou FF, Jha V, et al. Membranous nephropathy. Nat Rev Dis Primers. 2021;7:69.
Couser WG, Johnson RJ. The etiology of glomerulonephritis: roles of infection and autoimmunity. Kidney Int. 2014;86:905–14.
Article CAS PubMed Google Scholar
Radhakrishnan J, Perazella MA. Drug-induced glomerular disease: attention required! Clin J Am Soc Nephrol. 2015;10:1287–90.
Article PubMed PubMed Central Google Scholar
Plaisier E, Ronco P. Screening for cancer in patients with glomerular diseases. Clin J Am Soc Nephrol. 2020;15:886–8.
Article CAS PubMed PubMed Central Google Scholar
Sethi S. The many faces of NELL1 MN. Clin Kidney J. 2022;16:442–6.
Article PubMed PubMed Central Google Scholar
Caza TN, Hassen SI, Dvanajscak Z, Kuperman M, Edmondson R, Herzog C, et al. NELL1 is a target antigen in malignancy-associated membranous nephropathy. Kidney Int. 2021;99:967–76.
Article CAS PubMed Google Scholar
Caza TN, Larsen CP. Lipoic acid in neural epidermal growth factor-like 1-associated membranous nephropathy: more than a coincidence? Kidney Int. 2022;101:418–9.
Article CAS PubMed Google Scholar
Kurien AA, Prema KSJ, Walker P, Caza T. Traditional indigenous medicines are an etiologic consideration for NELL1-positive membranous nephropathy. Kidney Int. 2022;102:1424–6.
Article CAS PubMed Google Scholar
Iwakura T, Ema C, Isobe S, Fujikura T, Ohashi N, Kato A, et al. Prevalence of neural epidermal growth factor-like 1- and exostosin 1/exostosin 2-associated membranous nephropathy: a single-center retrospective study in Japan. Sci Rep. 2022;12:2967.
Article CAS PubMed PubMed Central Google Scholar
Münch J, Krüger BM, Weimann A, Wiech T, Reinhard L, Hoxha E, et al. Posttransplant nephrotic syndrome resulting from NELL1-positive membranous nephropathy. Am J Transpl. 2021;21:3175–9.
Moroni G, Ponticelli C. Secondary membranous nephropathy. A narrative review. Front Med (Lausanne). 2020;7:611317.
Article PubMed PubMed Central Google Scholar
Iida A, Wada Y, Hayashi J, Tachibana S, Inaba T, Iyoda M, et al. Membranous nephropathy caused by rheumatoid arthritis. CEN Case Rep. 2019;8:233–8.
Article PubMed PubMed Central Google Scholar
Miyazaki R, Ueda H, Hayashi A, Okabe M, Katsuma A, Shimizu A, et al. Neural epidermal growth factor-like 1-positive membranous nephropathy with rheumatoid arthritis. Kidney Int Rep. 2023;8:921–4.
Article PubMed PubMed Central Google Scholar
Uchiyama-Tanaka Y, Mori Y, Kishimoto N, Nose A, Kijima Y, Nagata T, et al. Membranous glomerulonephritis associated with hepatitis C virus infection: case report and literature review. Clin Nephrol. 2004;61:144–50.
Article CAS PubMed Google Scholar
Bjørneklett R, Vikse BE, Svarstad E, Aasarød K, Bostad L, Langmark F, et al. Long-term risk of cancer in membranous nephropathy patients. Am J Kidney Dis. 2007;50:396–403.
Alnasrallah B, Collins JF, Zwi LJ. Malignancy in membranous nephropathy: evaluation of incidence. Int J Nephrol. 2017;2017: e8409829.
Uhlen M, Zhang C, Lee S, Sjöstedt E, Fagerberg L, Bidkhori G, et al. A pathology atlas of the human cancer transcriptome. Science. 2017;357:eaan2507.
Wang G, Sun L, Dong H, Wang Y, Xu X, Zhao Z, et al. Neural epidermal growth factor–like 1 protein–positive membranous nephropathy in Chinese patients. Clin J Am Soc Nephrol. 2021;16:727–35.
Comments (0)